Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Profit After Tax (2023 - 2025)

Historic Profit After Tax for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to -$43.8 million.

  • CG Oncology's Profit After Tax fell 11469.25% to -$43.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$151.5 million, marking a year-over-year decrease of 10815.98%. This contributed to the annual value of -$88.0 million for FY2024, which is 8112.41% down from last year.
  • CG Oncology's Profit After Tax amounted to -$43.8 million in Q3 2025, which was down 11469.25% from -$41.4 million recorded in Q2 2025.
  • CG Oncology's Profit After Tax's 5-year high stood at -$8.7 million during Q1 2023, with a 5-year trough of -$43.8 million in Q3 2025.
  • Moreover, its 3-year median value for Profit After Tax was -$18.9 million (2024), whereas its average is -$23.3 million.
  • As far as peak fluctuations go, CG Oncology's Profit After Tax plummeted by 6276.59% in 2024, and later crashed by 11916.2% in 2025.
  • Over the past 3 years, CG Oncology's Profit After Tax (Quarter) stood at -$16.6 million in 2023, then plummeted by 92.07% to -$31.8 million in 2024, then plummeted by 37.77% to -$43.8 million in 2025.
  • Its last three reported values are -$43.8 million in Q3 2025, -$41.4 million for Q2 2025, and -$34.5 million during Q1 2025.